Differential expression of CD44 variants among meningioma subtypes

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 3, 1996, Pages

  Suzuki, S O ^a   Iwaki, T ^a   Kitamoto, T ^a   Mizoguchi, M ^a   Fukui, M ^a   Tateishi, J ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CD44; cell differentiation; meningioma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; EZRIN; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY GRANULE; SOUTHERN BLOTTING;

EID: 0029744343     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.49.3.m140     Document Type: Article

References (33)

1. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer 1994;8(Suppl):l 10-15.
2. Miyake K, Medina KL, Hayashi S. Monoclonal antibodies to Pgp-l/CD44 block lymphopoiesis in long-term bone marrow cultures. J Exp Med 1990;171:477-88.
3. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms (review). Cancer Cells 1991;3:347-50.
4. Ruiz P, Schwarzler C, Günthert U. CD44 isoforms during differentiation and development. Bioassays 1995;17:1724.
5. Toyama SN, Sorimachi H, TobitaY, Kitamura F,Yagita H, Suzuki K, Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. JBiol Chem 1995;270:7437-44.
6. Arai K, liai T, Nakayama M, Hasegawa K, Sato K, Ohtsuka K, et al. Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44 + L-selectin, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid. Immunology 1995;84:64-71.
7. Günthert U, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65:13-24.
8. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-7.
9. Tarin D, Bolodeoku J, Hartfill SJ, Sugino T, Woodman AC, Yoshida K. The clinical significance of malfunction of the CD44 locus in malignancy. J Neurooncol 1995;26:209-19.
10. Terpe HJ, Stark H, Prehm P, Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry 1994;101:79-89.
11. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, et al. Expression of CD44 in human lung tumors. Cancer Res 1994;54:1381-7.
12. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. 2nd edn. Berlin: Springer Verlag, 1993.
13. Kuppner MC, Van ME, Gauthier T, Hamou MF, de Tribolet N. Differential expression of the CD44 molecule in human brain tumours. Im J Cancer 1992;SO:572-7.
14. Harn HJ, Lee HS, Ho LI, Lee WH, Ding JH. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines. Biochem MolBiolInt 1994;33:743-9.
15. Chomczynski P, Sacci N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
16. Screaton GR, Bell MV, Jackson DG, Cornells FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sei USA 1992; 89:12160-4.
17. Kitamoto T, lizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaque. Biochem Biophys Res Commun 1993;192:525-31.
18. Ohgami T, Kitamoto T, Weidmann A, Beyreuther K, Tateishi J. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease. Am J Pathol 1991; 139:1245-50.
19. Iwaki T, Kume-Iwaki A, Liem R, Goldman J. aB-crystallin is expressed in non-leticular tissues and accumulates in Alexander's disease brain. Cell 1989;57:71-8.
20. Ohta M, Kitamoto T, Iwaki T, Ohgami T, Fukui M, Tateishi J. Immunohistochemical distribution of amyloid precursor protein during normal rat development. Dev Brain Res 1993;7S:151-61.
21. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M. MI l staining index and scoring of histologie features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 1994; 74:3176-89.
22. Shin RW, Iwaki T, Kitamoto T, Tateishi J. Hydrated autoclave pretreatment enhances Tau immunoreactivity in formalin-fixed normal and Alzheimer's desease brain tissues. Lab Invest 1991;64:693-702.
23. Takeshita I, Takaki T, Nakamura R, Maeyama R, Fukui M, Kitamura K. Established cell lines derived from human gliomas. Human Cell 1990;3:255-6.
24. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994;126:391-401.
25. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-8.
26. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
27. Driessens MHE, Stroeken PJM, Erena NFR, van der Valk MA, van Rijthoven EAM, Roos E. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J Cell Biol 1995;131:1849-55.
28. Alguacil GA, Pettigrew NM, Sima AA. Secretory meningioma. A distinct subtype of meningioma. Am J Surg Paî/zo/1986;10:102-11.
29. Ejeckam GC, Azadeh B, Hamad A. Secretory meningioma. Histopathology 1992;21:47 5-7.
30. Adachi J, Kazumoto K, Uki J, Takeda F, Kurozumi M, Nakazato Y. Secretory meningioma: a case report with immunohistochemical and ultrastructural study. Brain Tumor Pathology 1993;10:93-8.
31. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 1994;12S: 1371-84.
32. Meis JM, Ordonez NG, Burner JM. Meningiomas: an immunohistochemical study of 50 cases. Arch Pathol Lab Med 1986;110:934-7.
33. Schnitt SJ, Vogel H. Meningiomas: diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 1986;10:640-9.